Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-23

Clinical Trial Update: 5-HTP and Creatine for Depression [Phase 2]

View source ↗

Summary

A Phase 2 study investigating the combination of 5-HTP and creatine for major depressive disorder has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-HTP (5-hydroxytryptophan)
  • Creatine (creatine)

Snippet

Sponsor: University of Utah | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-07-23